Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.
about
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlCellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcriptionAngiomotin is a novel Hippo pathway component that inhibits YAP oncoproteinThe hippo signaling pathway in development and cancerIntegrative analysis of the melanoma transcriptomeIdentification and validation of oncogenes in liver cancer using an integrative oncogenomic approachCo-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesisTransforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentFour jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinomaTargeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer TherapyHippo/YAP pathway for targeted therapyThe Hippo-YAP pathway in organ size control and tumorigenesis: an updated versionSubtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysisCharacterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsCausal inference of gene regulation with subnetwork assembly from genetical genomics data.ACTuDB, a new database for the integrated analysis of array-CGH and clinical data for tumors.Breast tumor copy number aberration phenotypes and genomic instabilityA new classification method using array Comparative Genome Hybridization data, based on the concept of Limited Jumping Emerging Patterns.Normalized, segmented or called aCGH data?FACADE: a fast and sensitive algorithm for the segmentation and calling of high resolution array CGH dataEffects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome.A large scale survey reveals that chromosomal copy-number alterations significantly affect gene modules involved in cancer initiation and progression.Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancerYes-associated protein expression in head and neck squamous cell carcinoma nodal metastasisIntegrative molecular characterization of head and neck cancer cell model genomesDown-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.A head and neck cancer tumor response-specific gene signature for cisplatin, 5-fluorouracil induction chemotherapy fails with added taxanesYAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9.Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomasThe pathological significance of Notch1 in oral squamous cell carcinoma.MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.Sub-cellular localisation studies may spuriously detect the Yes-associated protein, YAP, in nucleoli leading to potentially invalid conclusions of its function.Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth.
P2860
Q24299106-3B82C5D7-A591-4A17-AAA0-23C924BB9987Q24306110-B092C427-13A9-4564-831A-9AA529392F82Q24323326-66425312-76C9-463D-B21B-421593DAA9AFQ24603986-B2552054-7643-491A-8096-68FC6CA8A092Q24608060-DD974A22-D054-4DCE-BED3-E3F69979C35AQ24633776-140CB208-8300-4EB4-9863-E1E2A64548EAQ24655172-53102807-1A00-40FA-A285-C1179493A83BQ24682018-7B3954E2-9585-4984-8FA9-1250119E9E47Q27025661-D84BBA18-FB2A-45CD-832D-98B59DD7D5B5Q27310820-AC380267-138E-4A9D-9695-EC752BAFD607Q28078129-3DEA84C7-BCE6-4D5B-83CD-14EE5F2786E8Q28088294-3CEA4F3F-3942-40AE-B2EE-821387392241Q28281214-977FC10F-70D4-49CB-9B40-A2D4DD4B96ACQ28391050-1F2D74A4-9751-4109-BB25-0399F22D5CD7Q28751743-D1FDF804-A025-4445-8B20-91DCDB28E988Q30711939-EDE15E4B-B613-4805-8531-22CDE8B7897CQ31112364-74D477F4-0462-4788-A298-1DB17A34BC0AQ33240170-4A8295F7-AC68-42ED-8300-E77BFAC08205Q33407921-D4D5D008-C81B-41AB-A1D4-5BB8345065CEQ33448578-83D10A08-04C4-439F-8F61-67849B315467Q33605550-8AFFD3E2-20E1-4587-829E-FF10B6B27E80Q33631459-D10FA691-BA33-4458-8D07-891E933289E0Q33720509-76CF5113-2211-43C6-8A59-B5E61832ED73Q33757057-6583718D-F80B-4440-A221-0EB18D9BA869Q33840816-9BC26F3C-1862-4424-943C-5909C80D826AQ33891540-882E903D-C10D-40A2-B971-5E9820B6FC50Q33943271-53F6AC33-4496-477D-81A5-F48E0E7F4F09Q34077954-B71731E4-D12E-4102-8EA2-EC3976D24038Q34091528-D3216880-4CE4-44D3-A79B-38E3A9A3CEF7Q34187277-D805D1F1-EC8E-4020-B78E-B460FE536BC4Q34349271-1E8E1004-02A8-45A5-91D9-AD8F7E614E3BQ34442876-41175798-271C-4669-B67E-1FF4591FD865Q34463878-5CB97C8D-25E8-4118-A51F-7F2265FB4728Q34581690-92D01B74-1B56-427A-8DCA-12A731AF0898Q34583947-C3F94C0A-D9F5-4A65-81AB-1899EBB2BAACQ34622885-A7EED267-D8A1-4BFA-B9A7-A8B746923985Q34655317-096BD38C-EC89-408B-8FE7-4D21F5DB0F89Q34960600-497320A0-97B2-4A02-ABC6-23E4027FA722Q35058951-DC27726A-511E-4C38-A371-BBC7555FF33BQ35089015-83206F4E-8B81-44FA-A25E-2329651F4747
P2860
Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Rare amplicons implicate frequ ...... oral squamous cell carcinoma.
@en
Rare amplicons implicate frequ ...... oral squamous cell carcinoma.
@nl
type
label
Rare amplicons implicate frequ ...... oral squamous cell carcinoma.
@en
Rare amplicons implicate frequ ...... oral squamous cell carcinoma.
@nl
prefLabel
Rare amplicons implicate frequ ...... oral squamous cell carcinoma.
@en
Rare amplicons implicate frequ ...... oral squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Rare amplicons implicate frequ ...... n oral squamous cell carcinoma
@en
P2093
Antoine M Snijders
Daniel Pinkel
Donna G Albertson
Jane Fridlyand
Nusi Dekker
Richard C K Jordan
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208601
P407
P577
2005-06-01T00:00:00Z